Jacob M. Kay
Director/Board Member bei CANNARA BIOTECH INC.
Vermögen: 150 015 $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Jacob M. Kay
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Agricultural Commodities/Milling | 18 | |
Apotex, Inc.
 Apotex, Inc. Pharmaceuticals: MajorHealth Technology Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada.
17
| Holding Company | Pharmaceuticals: Major | 17 |
| Public Company | Pharmaceuticals: Major | 16 | |
EmpowerPharm, Inc.
 EmpowerPharm, Inc. Pharmaceuticals: MajorHealth Technology EmpowerPharm, Inc. is a Canadian pharmaceutical company that specializes in developing prescription CBD tablets for anxiety sufferers. EmpowerPharm is based in Toronto, CA. The private company is led by healthcare and pharmaceutical professionals with over 450 years of cumulative industry experience. The company was founded by Peter Billiaert and Aubrey Dan, with Aubrey Dan serving as the CEO since incorporation.
5
| Private Company | Pharmaceuticals: Major | 5 |
Apotex Corp.
 Apotex Corp. Pharmaceuticals: MajorHealth Technology Apotex Corp. is a generic pharmaceuticals company, which offers generics, innovative molecules, and biotechnology products. The company was founded in 1999 and is headquartered in Weston, FL.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Juno Pharmaceuticals Corp.
 Juno Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jacob M. Kay
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| SPECTRAL MEDICAL INC. | Medical Specialties | Corporate Officer/Principal | |
| PALADIN LABS INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| BARR PHARMACEUTICALS INC | Pharmaceuticals: Generic | Director/Board Member | |
| AURORA CANNABIS INC. | Agricultural Commodities/Milling | Director/Board Member Chief Operating Officer | |
The Apotex Group of Cos.
 The Apotex Group of Cos. Pharmaceuticals: MajorHealth Technology The Apotex Group provides pharmaceutical research and development services. Its products include APO-Amoxi Clav, APO-Benazepril, APO-Bicalutamide, APO-Cefprozil and APO-Enalapril. The company was founded by Bernard Sherman in 1974 and is headquartered in Weston, Canada. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| McGill University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| York University | College/University | Masters Business Admin Undergraduate Degree | |
| Queen's University | College/University | Masters Business Admin Doctorate Degree Masters Business Admin | |
| CINKARNA CELJE, D. D. | Chemicals: Specialty | Chairman | |
Dancap Private Equity, Inc.
 Dancap Private Equity, Inc. Investment ManagersFinance Dancap Private Equity Inc (Dancap Private Equity) is a private equity firm founded in 2002 by Aubrey Dan. The firm is headquartered in Toronto, Ontario. | Investment Managers | Founder Director of Finance/CFO | |
| Dalhousie University | College/University | Graduate Degree | |
| University of Alberta | College/University | Masters Business Admin | |
| University of Toronto | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Biotechnology | President Director/Board Member | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Ontario Bar Association
 Ontario Bar Association Miscellaneous Commercial ServicesCommercial Services Ontario Bar Association operates as the voice of Canada’s legal profession. The firm represents lawyers, judges, notaries, law teachers and law students from across the province. It specializes in advocacy, practice area sanctions, professional development programs, and law reform and law amendment. The company was founded in 1896 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Polish Academy of Sciences | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Morluk Sp zoo | Chief Executive Officer | ||
The Canadian Generic Pharmaceutical Association
 The Canadian Generic Pharmaceutical Association Pharmaceuticals: GenericHealth Technology The Canadian Generic Pharmaceutical Association provides generic prescription medicines and active pharmaceutical ingredients. The company was founded in 1984 and is headquartered in Toronto, Canada. | Pharmaceuticals: Generic | Corporate Officer/Principal Chairman | |
| Akademia Medyczna | College/University | Graduate Degree | |
| Warszawski Uniwersytet Medyczny | College/University | Corporate Officer/Principal Doctorate Degree | |
| European Association For Cancer Research | Corporate Officer/Principal | ||
| ARCH BIOPARTNERS INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
European Academy of Dermatology & Venereology
 European Academy of Dermatology & Venereology Internet Software/ServicesTechnology Services The European Academy of Dermatology and Venereology (EADV) is an international community that shares and adopts best practices within dermatology and venereology. The EADV offers various membership categories, including benefits such as face-to-face and digital education, leadership development, and publications. The academy also provides funding opportunities for research, fellowships, and scholarships. The EADV hosts annual events such as the EADV Congress and EADV Symposium, where the latest research and trends in dermatology and venereology are shared. The academy also publishes clinical guidelines and articles on COVID-19. The EADV is committed to supporting the lifelong learning of dermatologists and venereologists and helping foster scientific advancements and practices in the prevention, diagnosis, and treatment of skin and venereal diseases. | Internet Software/Services | Corporate Officer/Principal | |
GreenLeaf Medical AB
 GreenLeaf Medical AB Food: Major DiversifiedConsumer Non-Durables GreenLeaf Medical AB provides natural ingredient food products. The private company is based in Stockholm, Sweden. The CEO of the Swedish company is Anders Struksnes. | Food: Major Diversified | Director/Board Member | |
| European Society of Dermatological Research | Director/Board Member | ||
| AIRWAY MEDIX S.A. | Medical Specialties | Chief Executive Officer | |
| ADIUVO INVESTMENTS S.A. | Biotechnology | Chief Executive Officer | |
Joint Polish Investment Fund Management BV
 Joint Polish Investment Fund Management BV Investment ManagersFinance Joint Polish Investment Fund Management BV (Joint Polish Investment Fund Management) is a venture capital firm founded in 2015. The firm headquartered in Netherlands. | Investment Managers | Private Equity Investor | |
| Warsaw Sky-Warszawskie Niebo Sp zoo | Corporate Officer/Principal | ||
| Glia Sp zoo | Director/Board Member | ||
| Venture Advisor Sp zoo | Director/Board Member | ||
| Adiuvo Management Sp zoo | Director/Board Member | ||
| Nutra Sp zoo | Chief Executive Officer | ||
| Essenoids Sp zoo | Chief Executive Officer | ||
| Adiuhealth AG | Director/Board Member | ||
| Cambridge Chocolate Technologies Ltd. | Director/Board Member | ||
| E-SHOPPING GROUP S.A. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Phase2 Microtechnologies, Inc.
 Phase2 Microtechnologies, Inc. Electronic ComponentsElectronic Technology Phase2 Microtechnologies, Inc. is a technology development company that offers Micro-Electro-Mechanical Systems-enabled pH sensor technology platforms. The company was founded in 2016 and is headquartered in Pittsburgh, PA. | Electronic Components | Director/Board Member | |
Sound Object Technologies SA
 Sound Object Technologies SA Packaged SoftwareTechnology Services Sound Object Technologies SA develops technology for obtaining and processing information from sound signals for application in medical devices. The company was founded by Adam Pluta and Piotr Smólski and in 2014 and is headquartered in Warsaw, Poland. | Packaged Software | Director/Board Member | |
Helix Immuno-Oncology SA
 Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistik
International
| Polen | 22 |
| Kanada | 19 |
| Vereinigte Staaten | 4 |
| Schweiz | 4 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 16 |
| Consumer Services | 10 |
| Finance | 4 |
| Process Industries | 3 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 171 |
| Corporate Officer/Principal | 77 |
| Independent Dir/Board Member | 48 |
| Chief Executive Officer | 42 |
| Chairman | 42 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Gale | 45 |
| William White | 27 |
| Marek Jan Orlowski | 25 |
| Barry Fishman | 22 |
| Donald Olds | 20 |
| Amy Satov | 17 |
| William Thomas Hodgson | 16 |
| Mario Gobbo | 14 |
| Lennie Ryer | 12 |
| David J. Cox | 12 |
| Henryk Klakurka | 11 |
| Steven Lydeamore | 10 |
| S. Slawomir Majewski | 10 |
| Aubrey Dan | 9 |
| R. Craig Baxter | 9 |
- Börse
- Insiders
- Jacob M. Kay
- Unternehmensverbindungen
